Release Date: 08/12/11 08:29 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 115.92KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling